<qa>  What is the name of the PATIENTs that are VELIPARIB, BVELIPARIB, BENDAMUSTINE HYDROCHLORIDE, AND RITUXIMAB IN TREATING PATIENTS WITH RELAPSED OR REFRACTORY LYMPHOMA, MULTIPLE MYELOMA, OR SOLID TUMORS: 